India to Hong Kong: Regorafenib Export Trade Route
India has recorded 1 verified shipments of Regorafenib exported to Hong Kong, representing a combined trade value of $28.5K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $28.5K USD. The leading Indian exporter is KARDI TRADING PRIVATE LIMITED, which accounts for 100% of total export value with 1 shipments worth $28.5K USD. On the buying side, SMC GLOBAL LIMITED is the largest importer in Hong Kong with $28.5K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Hong Kong Regorafenib corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $28.5K USD. The route is dominated by KARDI TRADING PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $28.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with regorafenib's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 17.1%, placing it at rank #12 among India's top regorafenib export destinations globally.
On the import side, key buyers of Indian regorafenib in Hong Kong include SMC GLOBAL LIMITED. SMC GLOBAL LIMITED is the single largest importer with 1 shipments valued at $28.5K USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#12
- Annual growth+17.1%
- Demand growth+14.8%
- Regulatory ease86/100
Top 10 Indian Regorafenib Exporters to Hong Kong
Showing top 10 of 1 Indian suppliers exporting Regorafenib to Hong Kong, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KARDI TRADING PRIVATE LIMITED Avg $28.5K per shipment | 1 | $28.5K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting regorafenib to Hong Kong, ranked by total trade value. The listed exporters are: KARDI TRADING PRIVATE LIMITED. KARDI TRADING PRIVATE LIMITED is the dominant supplier with 1 shipments worth $28.5K USD, giving it a 100% market share.
Top 10 Regorafenib Importers in Hong Kong
Showing top 10 of 1 known buyers in Hong Kong receiving Regorafenib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian regorafenib in Hong Kong include SMC GLOBAL LIMITED. The largest importer is SMC GLOBAL LIMITED, accounting for $28.5K USD across 1 shipments — representing 100% of all regorafenib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SMC GLOBAL LIMITED | 1 | $28.5K | 100.0% |
Top 10 Regorafenib Formulations Imported by Hong Kong
Showing top 10 of 1 product formulations shipped on the India to Hong Kong Regorafenib route, ranked by trade value
Hong Kong imports a wide range of regorafenib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — REGORAFENIB 40MG TABLETS(28S PACK) (350 BT) — accounts for $28.5K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | REGORAFENIB 40MG TABLETS(28S PACK) (350 BT) | 1 | $28.5K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 1 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's regorafenib exports to Hong Kong are driven primarily by a handful of large-scale manufacturers. KARDI TRADING PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Hong Kong benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — KARDI TRADING PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $28.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
On the buying side, SMC GLOBAL LIMITED is the largest importer with 1 shipments worth $28.5K USD — representing 100% of all regorafenib imports from India on this route.
Route Statistics
- Trade Volume
- $28.5K
- Avg. Shipment
- $28.5K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~19 days
- Annual Growth
- +17.1%
Related Analysis
Other Regorafenib Routes
Unlock the Full India to Hong Kong Regorafenib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — India to Hong Kong Regorafenib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Regorafenib to Hong Kong?
The leading Indian exporters of Regorafenib to Hong Kong are KARDI TRADING PRIVATE LIMITED. KARDI TRADING PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Regorafenib exports from India to Hong Kong?
India exports Regorafenib to Hong Kong worth approximately $28.5K USD across 1 recorded shipments. The average value per shipment is $28.5K USD.
Q Which ports does India use to ship Regorafenib to Hong Kong?
The most active port of origin is HYDERABAD AIR with 1 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Hong Kong for Regorafenib?
The average transit time for Regorafenib shipments from India to Hong Kong is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Hong Kong Regorafenib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.1% with demand growth tracking at 14.8%. The route is ranked #12 among India's top Regorafenib export destinations globally.
Q How many suppliers are active on the India to Hong Kong Regorafenib route?
There are currently 1 active Indian suppliers exporting Regorafenib to Hong Kong. The market is moderately concentrated with KARDI TRADING PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Regorafenib from India in Hong Kong?
The leading importers of Indian Regorafenib in Hong Kong include SMC GLOBAL LIMITED. SMC GLOBAL LIMITED is the largest buyer with 1 shipments worth $28.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Hong Kong export trade corridor identified from Indian Customs (DGFT) records for Regorafenib.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Hong Kong matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists